Organigram (OGI) announced that James Yamanaka, formerly global head of strategy for British American Tobacco (BTI), has been appointed the company’s new CEO. Yamanaka is expected to assume the role effective on or about January 15, 2026. Yamanaka will also join the company’s board of directors when he assumes the role of CEO.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OGI: